第 1 到 29 筆結果,共 29 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2008 | Viral hepatocarcinogenesis: From infection to cancer | Tan A.; Shiou-Hwei Yeh ; CHUN-JEN LIU ; Cheung C.; PEI-JER CHEN | Liver International | 102 | 84 | |
2 | 2021 | Unique features of hepatitis b virus-related hepatocellular carcinoma in pathogenesis and clinical significance | Wang S.-H.; Shiou-Hwei Yeh ; PEI-JER CHEN | Cancers | 11 | 11 | |
3 | 2013 | Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: The emerging role for radioembolization using yttrium-90 | Lau W.-Y.; Sangro B.; PEI-JER CHEN ; Cheng S.-Q.; Chow P.; Lee R.-C.; Leung T.; Han K.-H.; Poon R.T.P. | Oncology (Switzerland) | 127 | 121 | |
4 | 2013 | A systematic review and meta-analysis of adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma | Huang T.-S.; Shyu Y.-C.; Chen H.-Y.; Yuan S.-S.; Shih J.-N.; PEI-JER CHEN | Journal of Viral Hepatitis | 23 | 21 | |
5 | 2011 | Role of microRNAs in hepatitis B virus replication and pathogenesis | Liu W.-H.; Shiou-Hwei Yeh ; PEI-JER CHEN | Biochimica et Biophysica Acta - Gene Regulatory Mechanisms | 82 | 78 | |
6 | 2013 | Predicting clinical outcome in a patient with chronic hepatitis B virus infection | Yang H.-I.; PEI-JER CHEN | Clinical Liver Disease | 0 | 0 | |
7 | 2018 | The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA | HUNG-CHIH YANG ; PEI-JER CHEN | Virus Research | 41 | 33 | |
8 | 2006 | Post-translational modification of delta antigen of hepatitis D virus | Huang W.-H.; Chen C.-W.; Wu H.-L.; PEI-JER CHEN | Current Topics in Microbiology and Immunology | 46 | 38 | |
9 | 2016 | Perspectives on dual hepatitis B and C infection in Taiwan | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; TAI-CHUNG TSENG ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 13 | 12 | |
10 | 2006 | Natural course and treatment of hepatitis D virus infection | Hsieh T.-H.; CHUN-JEN LIU ; DING-SHINN CHEN ; PEI-JER CHEN | Journal of the Formosan Medical Association | 44 | 39 | |
11 | 2005 | Natural course and treatment of dual hepatitis B virus and hepatitis C virus infections | CHUN-JEN LIU ; JYH-MING LIOU ; DING-SHINN CHEN ; PEI-JER CHEN | Journal of the Formosan Medical Association | 45 | 36 | |
12 | 2017 | Management of hepatitis C virus infection in the Asia-Pacific region: an update | Lim S.G.; Aghemo A.; PEI-JER CHEN ; Dan Y.Y.; Gane E.; Gani R.; Gish R.G.; Guan R.; Jia J.D.; Lim K.; Piratvisuth T.; Shah S.; Shiffman M.L.; Tacke F.; Tan S.S.; Tanwandee T.; Win K.M.; Yurdaydin C. | The Lancet Gastroenterology and Hepatology | 48 | 43 | |
13 | 2010 | Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: Experts'opinion | PEI-JER CHEN ; Furuse J.; Han K.-H.; CHIUN HSU ; Lim H.-Y.; Moon H.; Qin S.; Ye S.-L.; Yeoh E.-M.; Yeo W. | Liver International | 37 | 34 | |
14 | 2000 | Impact of human genome research on medicine - The initial Taiwan experience | Tsai S.-F.; PEI-JER CHEN | Journal of the Formosan Medical Association | 1 | 1 | |
15 | 2020 | Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) | Chang F.-Y.; Chen H.-C.; PEI-JER CHEN ; Ho M.-S.; Hsieh S.-L.; Lin J.-C.; Liu F.-T.; Sytwu H.-K. | Journal of Biomedical Science | 34 | 26 | |
16 | 2013 | Immunocompetent nontransgenic mouse models for studying hepatitis B virus immune responses | Tzeng H.-T.; PING-NING HSU ; PEI-JER CHEN | Journal of Gastroenterology and Hepatology (Australia) | 9 | 7 | |
17 | 2007 | How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? | Amarapurkar D.N.; Hashimoto E.; Lesmana L.A.; Sollano J.D.; PEI-JER CHEN ; Goh K.-L. | Journal of Gastroenterology and Hepatology (Australia) | 329 | 313 | |
18 | 2013 | Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and management | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology International | 43 | 35 | |
19 | 2021 | Gut microbiota in the innate immunity against hepatitis B virus — implication in age-dependent HBV clearance | Wu, Li Ling; Huang, Ting Shuo; Shyu, Yu Chiau; Wang, Chih Lin; HURNG-YI WANG ; PEI-JER CHEN | Current Opinion in Virology | 6 | 4 | |
20 | 2010 | Gender disparity of hepatocellular carcinoma: The roles of sex hormones | Shiou-Hwei Yeh ; PEI-JER CHEN | Oncology | 204 | 187 | |
21 | 2015 | Gender disparity in chronic hepatitis B: Mechanisms of sex hormones | Wang S.-H.; PEI-JER CHEN ; Shiou-Hwei Yeh | Journal of Gastroenterology and Hepatology (Australia) | 90 | 79 | |
22 | 2012 | Emerging hepatitis B virus infection in vaccinated populations: A rising concern? | TUNG-HUNG SU ; PEI-JER CHEN | Emerging Microbes and Infections | 13 | 10 | |
23 | 2020 | Elimination of hepatitis B in highly endemic settings: Lessons learned in Taiwan and challenges ahead | CHUN-JEN LIU ; PEI-JER CHEN | Viruses | 25 | 19 | |
24 | 2013 | Effect of Parenteral Selenium Supplementation in Critically Ill Patients: A Systematic Review and Meta-Analysis | Huang T.-S.; Shyu Y.-C.; Chen H.-Y.; Lin L.-M.; Lo C.-Y.; Yuan S.-S.; PEI-JER CHEN | PLoS ONE | 96 | 97 | |
25 | 2009 | Dual chronic hepatitis B virus and hepatitis C virus infection | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN | Hepatology International | 43 | 37 | |
26 | 2010 | Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions | Ahn S.H.; Chan H.L.Y.; PEI-JER CHEN ; Cheng J.; Goenka M.K.; Hou J.; Lim S.G.; Omata M.; Piratvisuth T.; Xie Q.; Yim H.J.; Yuen M.-F. | Hepatology International | 38 | 41 | |
27 | 2016 | Chronic Hepatitis B virus infection | Yuen M.-F.; Ahn S.H.; Chen D.-S.; PEI-JER CHEN ; Dusheiko G.M.; Hou J.-L.; Maddrey W.C.; Mizokami M.; Seto W.-K.; Zoulim F.; Lai C.-L. | Journal of Clinical Gastroenterology | 36 | 41 | |
28 | 2022 | Changing epidemiology of liver disease in Asia: Dual infection of HBV and HCV | CHUN-JEN LIU ; PEI-JER CHEN | Liver International | 12 | 9 | |
29 | 2010 | Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma | Omata M.; Lesmana L.A.; Tateishi R.; PEI-JER CHEN ; Lin S.-M.; Yoshida H.; Kudo M.; Lee J.M.; Choi B.I.; Poon R.T.P.; Shiina S.; ANN-LII CHENG ; Jia J.-D.; Obi S.; Han K.H.; Jafri W.; Chow P.; Lim S.G.; Chawla Y.K.; Budihusodo U.; Gani R.A.; Lesmana C.R.; Putranto T.A.; Liaw Y.F.; Sarin S.K. | Hepatology International | 881 | 860 |